Literature DB >> 31401450

Simultaneous determination of five active alkaloids from Compound Kushen Injection in rat plasma by LC-MS/MS and its application to a comparative pharmacokinetic study in normal and NSCLC nude rats.

Song Cang1, Ran Liu1, Tianyang Wang1, Xiaoyan Jiang1, Wenhua Zhang1, Kaishun Bi1, Qing Li2.   

Abstract

Non-small cell lung cancer (NSCLC), as the most common histological type of lung cancer with high mortality rates, has been widely treated by Compound Kushen Injection (CKI) in China. Among various active components with many pharmacologic properties, matrine, oxymatrine, sophoridine, oxysophocarpine and N-methylcytisine, are the main bioactive alkaloids of CKI. Therefore, a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed to simultaneously quantify the five alkaloids in nude rat plasma in this study. With aminopyrine as internal standard (IS), plasma samples were extracted by alkalified chloroform and then separated on an Agela Venusil MP C18 column (2.1 mm × 100 mm, 3 μm) using gradient elution. Water containing 10 mmol/L ammonium acetate (adjusted to pH 8.0 with ammonia water, A) and methanol (B) constituted the mobile phase system. Notably, the analysis was rapid and accurate due to a short running time of 6 min and a stereoisomer separation between matrine and sophoridine. Detection was implemented in MRM mode with an electrospray positive ionization source. Validation parameters were all in accordance with current criterion. The established method has been effectively employed to compare the pharmacokinetic behaviors of five alkaloids between normal and NSCLC nude rats. Results indicated that the pharmacokinetic behaviors of oxymatrine, sophoridine and N-methylcytisine from CKI could be changed when it was intravenously administrated to the NSCLC model rats, and possible reasons have been proposed. This study could provide meaningful reference for further clinical medication of CKI when combined with time-effect curve and clinical symptoms.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Active alkaloids; Compound Kushen Injection; LC-MS/MS; Non-small cell lung cancer; Pharmacokinetics

Mesh:

Substances:

Year:  2019        PMID: 31401450     DOI: 10.1016/j.jchromb.2019.121734

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Toxicokinetics of 11 Gelsemium Alkaloids in Rats by UPLC-MS/MS.

Authors:  Xiuwei Shen; Jianshe Ma; Xianqin Wang; Congcong Wen; Meiling Zhang
Journal:  Biomed Res Int       Date:  2020-07-15       Impact factor: 3.411

2.  Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD82 Cell Line.

Authors:  Shuo Wang; Jiang Chen; Hongyu Li; Xingshun Qi; Xu Liu; Xiaozhong Guo
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.